共 47 条
Evaluation of [11C]CB184 for imaging and quantification of TSPO overexpression in a rat model of herpes encephalitis
被引:14
作者:
Vallez Garcia, David
[1
]
de Vries, Erik F. J.
[1
]
Toyohara, Jun
[2
]
Ishiwata, Kiichi
[2
]
Hatano, Kentaro
[3
]
Dierckx, Rudi A. J. O.
[1
]
Doorduin, Janine
[1
]
机构:
[1] Univ Groningen, Univ Med Ctr Groningen, Dept Nucl Med & Mol Imaging, NL-9700 RB Groningen, Netherlands
[2] Tokyo Metropolitan Inst Gerontol, Res Team Neuroimaging, Tokyo 1730015, Japan
[3] Natl Ctr Geriatr & Gerontol, Ctr Dev Adv Med Dementia, Dept Clin & Expt Neuroimaging, Obu, Aichi 4748522, Japan
关键词:
PET;
TSPO;
PBR;
Neuroinflammation;
Rat;
PERIPHERAL BENZODIAZEPINE-RECEPTOR;
PROTEIN;
18;
KDA;
POSITRON-EMISSION-TOMOGRAPHY;
PET RADIOLIGAND;
BINDING-SITES;
BRAIN;
MICROGLIA;
TARGET;
LIGAND;
NEUROINFLAMMATION;
D O I:
10.1007/s00259-015-3021-x
中图分类号:
R8 [特种医学];
R445 [影像诊断学];
学科分类号:
1002 ;
100207 ;
1009 ;
摘要:
Purpose Evaluation of translocator protein (TSPO) overexpression is considered an attractive research tool for monitoring neuroinflammation in several neurological and psychiatric disorders. [C-11]PK11195 PET imaging has been widely used for this purpose. However, it has a low sensitivity and a poor signal-to-noise ratio. For these reasons, [C-11]CB184 was evaluated as a potentially more sensitive PET tracer. Methods A model of herpes simplex encephalitis (HSE) was induced in male Wistar rats. On day 6 or 7 after virus inoculation, [C-11]CB184 PET scans were acquired followed by ex vivo evaluation of biodistribution. In addition, [C-11]CB184 and [C-11]PK11195 PET scans with arterial blood sampling were acquired to generate input for pharmacokinetic modelling. Differences between the saline-treated control group and the virus-treated HSE group were explored using volumes of interest and voxel-based analysis. Results The biodistribution study showed significantly higher [C-11]CB184 uptake in the amygdala, olfactory bulb, medulla, pons and striatum (p < 0.05) in HSE rats than in control rats, and the voxel-based analysis showed higher bilateral uptake in the pons and medulla (p < 0.05, corrected at the cluster level). A high correlation was found between tracer uptake in the biodistribution study and on the PET scans (p < 0.001, r (2) = 0.71). Pretreatment with 5 mg/kg of unlabelled PK11195 effectively reduced (p < 0.001) [C-11]CB184 uptake in the whole brain. Both, [C-11]CB184 and [C-11]PK11195, showed similar amounts of metabolites in plasma, and the binding potential (BPND) was not significantly different between the HSE rats and the control rats. In HSE rats BPND for [C-11]CB184 was significantly higher (p < 0.05) in the amygdala, hypothalamus, medulla, pons and septum than in control rats, whereas higher uptake of [C-11]PK11195 was only detected in the medulla. Conclusion [C-11]CB184 showed nonspecific binding to healthy tissue comparable to that observed for [C-11]PK11195, but it displayed significantly higher specific binding in those brain regions affected by the HSE. Our results suggest that [C-11]CB184 PET is a good alternative for imaging of neuroinflammatory processes.
引用
收藏
页码:1106 / 1118
页数:13
相关论文